Progress Continues in Islet Transplantation, Immunosuppression Alternatives & New Sources of Cells
At the 14th World Congress of the International Pancreas and Islet Transplant Association (IPITA), UC San Francisco faculty presented the latest in islet transplantation, and shared exciting progress in stopping islet and tissue rejection through regulatory T cells (Tregs) and creating new sources of insulin-producing beta cells.
World Congress chair, Peter Stock, MD, PhD, co-leads the UCSF islet transplantation program, along with Andrew Posselt, MD, PhD. For a full report of the progress shared by UCSF researchers at IPITA, read this comprehensive story written by Jeffrey Norris in UCSF Public Affairs. Click here to read the article .